Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05696899 · ClinicalTrials.gov registry record · NA
Determining the Efficacy of Essential Oil Aromatherapy in Children Undergoing Port Access
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT05696899: Completed NA study, sponsored by Stanford University.
NCT05696899 is a NA study that has completed, run by Stanford University. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05696899, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the use of aromatherapy impacts patient anxiety and pain scores surrounding port access in pediatric oncology patients between the ages of 4 years and 18 years.
Interventions
- OTHER STILL QuickTAB Medipack blended scent aromatherapy, manufactured by Soothing Scents
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2023-12-05 |
| Est. Completion | 2024-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05696899
The ClinicalTrials.gov registry entry for NCT05696899 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which STILL QuickTAB Medipack blended scent aromatherapy, manufactured by Soothing Scents is the first listed.
NCT05696899 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05696899 about?
NCT05696899 is a clinical study titled "Determining the Efficacy of Essential Oil Aromatherapy in Children Undergoing Port Access". The purpose of this study is to determine if the use of aromatherapy impacts patient anxiety and pain scores surrounding port access in pediatric oncology patients between the ages of 4 years and 18 years.
What is the current status of trial NCT05696899?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2023-12-05. Estimated completion is 2024-05-30.
What interventions are being tested in trial NCT05696899?
The interventions under investigation include: STILL QuickTAB Medipack blended scent aromatherapy, manufactured by Soothing Scents (OTHER).
Who is sponsoring clinical trial NCT05696899?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.